Controlling glycated hemoglobin prevent diabetic retinopathy

AJBM crossMark

Philip Patel¹*, Alan Craig¹, Bruce Jun¹, Neil Poulter¹, H G Rennke¹


The overall number of patients with Diabetic retinopathy (DR) will continue to increase in parallel with the increasing global pandemic of type 2 diabetes. Diabetic retinopathy is the most common cause of visual loss in United Kingdom. A systematic medline search was conducted initially using the following keywords: clinical trials, diabetic retinopathy, hyperglycemia, macular edema, visual loss. Relevant abstracts and computer links to these abstracts were reviewed and a preliminary list of possible articles from this search was compiled. Next, the original articles from the list were retrieved and evaluated. Based on landmark of data, DR have become preventable by controlling hyperglycemia targeting HbA1c<7.0%, with other multifactorial treatment.
Keywords: Diabetic retinopathy; Hyperglycemia; Diabetes

Copyright © 2017 by The American Society for BioMedicine and BM-Publisher, Inc.

Article citationReferencesFull-Text/PDFFeedback
The citation data is computed by the following citation measuring services:

Google scholarcitedby

  1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14. [PubMed] [Cross Ref]
  2. Bhowmik B, Binte Munir S, Ara Hossain I, et al. Prevalence of type 2 diabetes and impaired glucose regulation with associated cardiometabolic risk factors and depression in an urbanizing rural community in Bangladesh: a population-based cross-sectional study. Diabetes Metab J 2012;36:422-32. [PMC free article][PubMed] [Cross Ref]
  3. Rahim MA, Khan AK, Ali SM, Nahar Q, Shaheen A, Hussain A. Glucose tolerance in a rural population of Bangladesh. Int J Diabetes Dev Ctries 2008;28:45-50. [PMC free article] [PubMed][Cross Ref]
  4. Nazir A, Papita R, Anbalagan VP, Anjana RM, Deepa M, Mohan V. Prevalence of diabetes in Asian Indians based on glycated hemoglobin and fasting and 2-H post-load (75-g) plasma glucose (CURES-120). Diabetes Technol Ther 2012;14:665-8. [PubMed] [Cross Ref]
  5. Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for diabetes and impaired glucose tolerance in Asian Indians: a community survey from urban eastern India. Diabetes Metab Syndr 2012;6:96-101. [PubMed] [Cross Ref]
  6. Anjana RM, Pradeepa R, Deepa M, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdiaDIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-7. [PubMed] [Cross Ref]
  7. Deepa M, Anjana RM, Manjula D, Narayan KM, Mohan V. Convergence of prevalence rates of diabetes and cardiometabolic risk factors in middle and low income groups in urban India: 10-year follow-up of the Chennai Urban Population Study. J Diabetes Sci Techol 2011;5:918-27. [PMC free article] [PubMed] [Cross Ref]
  8. Nathan DM, Kuenen J, Borg R, et al. A1c-derived average glucose (ADAG) study group: Translating the A1c assay into estimated average glucose values. Diabetes Care 2008;31:1-6. [PMC free article] [PubMed]
  9. Lenters-Westra E, Slingerland RJ. Hemoglobin A1c determination in the A1C-Derived Average Glucose (ADAG) study. Clin Chem Lab Med 2008;46:1617-23.[PubMed]
  10. Edelson GW, Fachnie JD, Whitehouse FW. Perioperative management of diabetes. Henry Ford Hosp Med J 1990;38:262-5. [PubMed]
  11. Root HF. Preoperative medical care of the diabetic patient. Postgrad Med 1966;40:439-44. [PubMed]
  12. Jacober SJ, Sowers JR. An update on perioperative management of diabetes. Arch Intern Med. 1999;159:2405-11. [PubMed]
  13. Risum O, Abdelnoor M, Svennevig JL, et al. Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. Scand J Thorac Cardiovasc Surg 1996;30:71-5. [PubMed]
  14. Rehman HU, Mohammed K. Perioperative management of diabetic patients. Curr Surg 2003;60:607-11. [PubMed]
  15. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999;67:1045-52. [PubMed]
  16. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82. [PubMed]
  17. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998;22:77-81. [PubMed]
  18. Mann JF, Schmieder RE, McQueen M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008;372:547-553. [PubMed]
  19. Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 2013;369:1892-1903. [PubMed]
  20. Kang YS, Ko GJ, Lee MH, et al. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats. Nephrol Dial Transplant 2009;24:73-84. [PubMed]
  21. Rachmani R, Slavachevsky I, Amit M, et al. The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. Diabet Med 2004;21:471-475. [PubMed]
  22. Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving HH. Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study. Diabetes Care 2005;28:2106-2112. [PubMed]



1. Access this article through OpenAthens

2. Access this article through your login credentials/Subscription

Get Access

3. Purchase this article at rate $55.00 and received Full-Text/PDF
You will have online immediate access to article following the completion of this purchase and you may download and print a copy of each article for your personal use. Use the coding below to purchase your article as PDF by credit card, debit card, will be asked to supply your billing card information. Before continue with your purchase please read carefully the BM-Publisher terms and conditions of purchase.

Purchase Article

For any technique error please contact us and will be response to sending purchase article by email.

Who Can Become a Reviewer?
Any expert in the article's research field can become a reviewer with American Journal of Biomedicine. Editors might ask you to look at a specific aspect of an article,...

Find out more

Thank you for visiting American Journal of BioMedicine. * = Required fields

Error: Contact form not found.

Topic Review
American Journal of BioMedicine Volume 5, Issue 2, pages 105-117
Received October 04, 2016; accepted January 18, 2017; published February 22, 2017

How to cite this article
Patel P, Craig¹ A, Jun B, Poulter N, Rennke HG. Controlling glycated hemoglobin prevent diabetic retinopathy. American Journal of BioMedicine 2017;5(2):105-117.

Article outline
1. Abstract
2. Keywords
3. Introduction
4. Methods
5. Results
6. Discussion
7. References